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Abstract During a two-stage revision for prosthetic joint
infections (PJI), joint aspirations, open tissue sampling
and serum inflammatory markers are performed before
re-implantation to exclude ongoing silent infection. We
investigated the performance of these diagnostic proce-
dures on the risk of recurrence of PJI among asymptom-
atic patients undergoing a two-stage revision. A total of
62 PJI were found in 58 patients. All patients had intra-
operative surgical exploration during re-implantation, and
48 of them had intra-operative microbiological swabs.
Additionally, 18 joint aspirations and one open biopsy
were performed before second-stage reimplantation.
Recurrence or persistence of PJI occurred in 12 cases
with a mean delay of 218 days after re-implantation, but
only four pre- or intraoperative invasive joint samples
had grown a pathogen in cultures. In at least seven
recurrent PJIs (58%), patients had a normal C-reactive
protein (CRP, <10 mg/l) level before re-implantation.
The sensitivity, specificity, positive predictive and nega-
tive predictive values of pre-operative invasive joint
aspiration and CRP for the prediction of PJI recurrence
was 0.58, 0.88, 0.5, 0.84 and 0.17, 0.81, 0.13, 0.86,
respectively. As a conclusion, pre-operative joint aspira-
tion, intraoperative bacterial sampling, surgical explora-
tion and serum inflammatory markers are poor predictors
of PJI recurrence. The onset of reinfection usually occurs
far later than reimplantation.
Introduction
A two-stage revision is an acknowledged procedure for the
treatment of infected arthroplasties (PJI) [1]. Infection
recurrence after re-implantation harbours significant mor-
bidity [2, 3], and every effort should be made to identify
patients at risk of such a devastating complication.
Normally, an interval of eight weeks is required between
infected implant removal and reimplantation, although there
are no uniform recommendations about the duration of this
interval, ranging from two to four weeks [1] to several
months [4, 5]. For patients undergoing an antibiotic-free
window before re-implantation, the interval between two
stages may be divided into a six-week course of antibiotic
treatment [3], followed by at least two additional weeks of
an antibiotic-free window [1, 3, 6]. A minimal delay of at
least two weeks seems to be important, because it has been
shown that periprosthetic tissue culture sensitivity is less
than 50%, if antimicrobial therapy was discontinued less
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than 14 days before sampling [5]. In the absence of clinical
signs and the presence of normal serum inflammatory
markers [6], re-implantation is undertaken. Additionally, a
joint aspiration or open biopsy is often performed before
re-implantation [3] to exclude asymptomatic persistent
infection. However, this empirical approach in PJI man-
agement is mostly based upon speculation and experts’
recommendations, rather than scientific evidence.
Recently, Müller et al. evaluated the values of serum C-
reactive protein (CRP) and pre-operative joint aspiration in
the predilection of persistent infection [7]. The utility of
CRP was equally assessed among 109 patients undergoing
second-stage reimplantation for infected knee prostheses
[8]. Both studies found only a poor or moderate perfor-
mance for both methods.
In this study, we investigate PJIs that recurred after a
two-stage revision with an emphasis on the utility of pre-
operative joint aspiration, serum inflammatory markers,
intra-operative sampling, surgical exploration and histology
obtained during re-implantation.
Materials and methods
Setting
The Geneva University Hospitals is a tertiary centre for
Orthopaedic Surgery and Traumatology. The Orthopaedic
Service has 132 acute care beds, a dedicated Infectious
Diseases physician [9] and performs more than 500
arthroplasties annually. The Service conducts a hip and
knee arthroplasty registry with active post-discharge sur-
veillance [10]. One day of hospitalisation costs roughly US
$1200. A surgical tissue sampling for bacterial testing costs
$6,500 (including anaesthesia, occupation of the operating
theatre, nursing, medical treatment and analyses). The
expenses for CRP sampling and leukocyte counts are about
$10 each. The cost for the treatment of a single episode of
PJI is about $45,000.
Study design
We performed a single-centre retrospective analysis from
January 1996 to June 2009. We included all PJI cases
treated by two-stage revision with a minimal follow-up of
six months post-reimplantation. Two physicians (M.S. and
I.U.) independently collected 61 variables for each PJI.
Definition of PJI required pus around the affected arthro-
plasty and/or at least three identical pathogens in microbi-
ological samples. We collected all CRP samples between
explantation and re-implantation with the exception of
patients with other causes of serum CRP alterations (i.e.
active neoplasm, autoimmune disease, cirrhosis Child B
and C). The CRP follow-up of the individual patients
under antibiotic treatment was stratified in weekly
periods during the first three weeks. The CRP value at
the end of each week post-explantation ± one day, e.g.
after seven days, or after 14 days post-explanation, was
noted on an EXCEL sheet. In contrast, CRP samples
performed within 15 days preceding re-implantation were
defined as pre-implantational samples. The normal upper
limits for CRP, total leukocyte count, and left shift were
given by our accredited laboratory and set for <10 mg/l,
<10 G/l, and <5% of non-segmented neutrophils,
respectively.
Microbiological assessment procedures were unchanged
during the study period. They were based on the Clinical
and Laboratory Standards Institute’s recommendations [11].
For direct microscopic examination Gram and Acridine-
staining were used. Histology (obtained during reimplanta-
tion without frozen section) was considered positive if
pathogens were detected or if the sample revealed at least
ten neutrophils per high-power field. There was no ethical
committee approval necessary.
Statistical methods
We investigated potential clinical risk factors for recurrent
PJI. To avoid model overfitting and spurious results, no
multivariate analysis was performed. Group comparisons
between PJI with and without recurrence were performed
by the Wilcoxon-rank sum or the Fisher exact test, as
appropriate. P values ≤0.05 (all two-tailed) were signifi-
cant. STATA™ software (9.0, STATA Corp, College
Station, USA) was used.
Results
General and microbiological results
A total of 62 PJI, treated with a two-stage exchange
procedure, were found in 58 patients (mean age 68 years;
29 women). Patients were followed-up for an average of
3.3 years after reimplantation. The PJI involved hip
arthroplasties (n=36, 58%), knee arthroplasties (n=23,
37%), hip hemiarthroplasties (n=2), and one shoulder
arthroplasty. The pathogens were Staphylococcus aureus
(n=15, of which four were methicillin-resistant), coagulase-
negative staphylococci (n=18), streptococci (n=15),
Enterococcus faecalis (n=1), anaerobes (n=2), Gram-
negative aerobic bacteria (n=7), and culture-negative PJI
(n=4). In 32 cases (32/62, 52%), patients were immuno-
compromised by diabetes mellitus (n=8), severe alcohol-
ism (n=7), neoplasms (n=6), steroid medication for
autoimmune disease (n=3), HIV (n=1), or affected by a
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combination of several immunosuppressive diseases listed
above (n=7).
Treatment procedure
The median duration of antibiotic therapy after prosthesis
explantation was 44 days (range, 28–105 days). In 54 PJI
(54/62, 87%), antibiotics had been stopped after an average
of 109 days (range, 2–634 days) before re-implantation; in
41 cases this window lasted more than 14 days. The
prolonged antibiotic-free windows were due to organisa-
tional difficulties, patient’s comorbidities, and social prob-
lems rather than problems related to infection. In eight
cases (8/62, 13%), re-implantation took place during
ongoing antibiotic treatment. During the prosthesis-free
interval, a gentamicin-loaded spacer was used in ten of 23
knee PJIs (43%). For an additional 11 knee PJIs (48%), a
spacer without antibiotic loading was used. For all hip PJIs,
explantation without transient spacer was the treatment of
choice.
Recurrence of PJI
In 12 cases (12/62, 19%), PJI recurred after reimplanta-
tion with a mean and median delay of 218 and 88 days,
respectively (Table 1). All PJI were surgical site infections
without evidence for haematogenous origin. All recurren-
ces were given postoperative antibiotic treatment for a
median duration of 46 (range, 9–93) days. Six recurrences
were successfully treated with debridement and arthro-
plasty retention. In three cases, patients underwent another
two-stage exchange. A second recurrence did not occur for
these nine cases. One case was treated with lifelong
suppressive antibiotic treatment and two cases were lost to
follow-up.
Microbiological sampling before re-implantation
A total of 19 invasive diagnostic procedures were performed
in 18 patients before re-implantation (18/62, 29%) including
18 joint aspiration procedures (median 33 days before re-
implantation, range 0–205 days) and one open biopsy
(126 days before). No iatrogenic complications were observed
as a result of these invasive procedures (Table 1).
Intraoperative Gram-staining
A total of 48 PJI episodes (48/62; 77%) underwent intra-
operative Gram- and Acridine orange staining during re-
implantation (average 3.3 samples). In all but one case, the
samples were free of leucocytes and staining failed to
reveal pathogens. The only exception was a recurrent PJI
due to S. aureus (last case of Table 1). This case was also
the only one revealing clinical pus at the operation site
among all study patients (1/62; 1.6%).
Intraoperative cultures
In three cases, the presence of bacteria was interpreted as
true pathogens, since they were identical to those respon-
sible for the PJI and were subsequently treated with
antibiotics. In one case, Corynebacterium sp (one of four
samples) was interpreted as contamination and was not
treated with antibiotics after reimplantation.
In summary, in 53 of 62 PJI, an invasive microbiological
sample before reimplantation was performed. Among these,
48 episodes (48/53, 91%) had an antibiotic-free interval
longer than 14 days (13/19 preoperative invasive samples,
and 35/48 intraoperative invasive samples).
Performance of various tests
In summary, in seven recurrent PJIs (7/12, 58%), pre-
reimplantational aspiration, open biopsy, intra-operative
surgical status and intra-operative cultures were negative.
For these invasive diagnostic procedures altogether, the
sensitivity, specificity, positive predictive and negative
predictive values for recurrent PJI were 0.58, 0.88, 0.5,
and 0.84, respectively (Table 2).
Histology
A total of 18 re-implantations were accompanied by
histology. No histological sample revealed the presence of
pathogens but four showed marked inflammation (4/18,
22%). Sensitivity, specificity, positive and negative predic-
tive values for recurrent PJI were 0.33, 0.8, 0.25, and 0.86,
respectively (Table 2).
Serum inflammatory markers before reimplantation
Total leukocyte count was elevated in three cases (mean
value 6.2 G/l; median three days before reimplantation).
Neutrophil left shift was always within normal range.
Pre-reimplantational serum CRP levels (mean value
10.0 mg/l; range 1–54 mg/l) were sampled in 42 cases
(42/62; 68%; median three days before reimplantation). In
eight of them, CRP values were above normal limit.
Among eight patients without normalisation of CRP levels
before reimplantation, one had recurrent infection and
seven did not (Fisher exact-test, p=1.0). In seven recurrent
PJIs (58%), patients had a normal C-reactive protein (CRP,
<10 mg/l) level before re-implantation. Sensitivity, speci-
ficity, positive predictive and negative predictive values of
elevated CRP levels for recurrent PJI were 0.17, 0.81, 0.13,
and 0.86, respectively (Table 2).
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CRP values throughout the antibiotic treatment
In the interval between explantation and reimplantation, a
total of 366 CRP samples were performed in the study
population without concomitant causes of serum CRP
alteration. After starting antibiotic treatment, CRP values
fell 90% within a mean of 30 days and a median of 20 days
(range, 6–93 days) and returned to normal within a mean of
38 days and a median of 27 days (range, 9–93 days). The
patient populations with and without recurrent PJI after
reimplantation did not differ in post-explantational peak
values (median 208 mg/l vs. 172 mg/l, Wilcoxon rank sum
test, p=0.65), time until CRP normalisation (median
35 days vs. 19 days, Wilcoxon rank sum test, p=0.20) or
delay until 90% decrease of initial CRP values (median
26 days vs. 16 days, Wilcoxon rank sum test, p=0.13). The
median CRP levels at the end of each week during the first
three weeks post-explantation did not differ between
infected vs. uninfected patients (all Wilcoxon-rank sum
tests; p>0.20).
Comparisons between PJI episodes
with and without recurrences
Neither group differed according to key parameters
(Table 3).
Discussion
We report a poor performance of pre-operative invasive
microbiological sampling, intraoperative surgical explora-
tion, or pre-reimplantational serum inflammatory markers
for recurrent infections among asymptomatic patients
undergoing a two-stage revision. None of the patients
presented signs of persistent infection during the antibiotic-
free window, regardless of duration, while awaiting re-
implantation. No clinical parameter showed specific asso-
ciation with recurrence (Table 3). Our recurrence risk of
19% was similar to the 20% published by Hanssen and
Osmon [12], the 21% indicated by Ghanem et al. [8] and to
other reports of two-stage [3, 13] or one-stage exchanges
[14, 15], even if lower recurrence rates have also been
reported [6, 16]. Therefore, we would exclude a substantial
therapeutic bias.
The landmark publication of Zimmerli et al. cites that at
least three intraoperative tissue specimens should be
sampled for culture [1], which is common practice,
although some experts ideally recommend up to six
specimens [17]. In our study population, the average
number of intraoperative microbiologic samples was 3.3,
and only a quarter of all reimplantations revealed less than
three samples (Table 1). Therefore we equally exclude a
major sampling bias.
Recurrent PJI occurred far later than the reimplantation
procedure and was solely detected on the basis of patient’s
complaints. While our average delay of recurrence was
seven months after reimplantation, it was 13 months [2] or
66 months [6] in other reports. We think that the usual six-
week antibiotic course may heal, or at least suppress
infection, to such a low level that current standard
laboratory procedures might not be able to detect them.
Pathogens need time to recover and to provoke recurrent
clinical infection. It is likely that the length of the
antibiotic-free window would not play a major role, since
these pathogens may remain dormant for years in the
absence of a new implant, and are awakened only in the
presence of a new one; a phenomenon observed in recurrent
osteomyelitis [18].
The low accuracy of intraoperative Gram-staining in PJI
diagnosis has been previously reported [19]. Additionally,
Müller et al. evaluated the values of preoperative cultures in
Diagnostic Recurrence of arthroplasty
infection
No recurrence of
arthroplasty infectiona
Invasive samplingsb
Presence of pathogens 5 5
Absence of pathogens 7 36
Serum C-reactive protein levels
10 mg/l and more 1 7
Normal values 5 29
Serum total leukocyte counts
10 G/l and more 0 3
Normal values 4 47
Histology from invasive samples
Inflammation 1 3
No inflammation detected 2 12
Table 2 Performances of
diagnostic procedures before
re-implantation of arthroplasties
a After re-implantation
b Pre-operative needle aspiration
before re-implantation, biopsies
and intra-operative microbiologi-
cal sampling
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the diagnosis of PJI [7]. Interestingly, their sensitivity,
specificity, positive and negative predictive values were
0.57, 0.5, 0.78 and 0.29, respectively. While our sensitivity
level was similar to theirs (0.58), specificity and negative
predictive values were better (0.88 and 0.84, respectively).
Of note, the study by Müller et al. investigated a
heterogeneous group of 50 patients with suspected PJI,
while in our retrospective study, invasive joint aspiration
has been performed in proven, formerly severe infections
upon reimplantation [7]. Thus, we initially expected a bias
towards a higher likelihood of detection of persistent
infection than reported for first time diagnosis. This was
not the case, which was also found by Mont et al., who
prospectively assessed infected knee arthroplasties with a
two-stage exchange and pre-revisional cultures in one arm
and none in the other. Statistically, the “overall infection
rate” was not significantly different between both groups
(5/35 vs. 3/34 of recurrence) [3].
It is questionable whether normal serum inflammatory
markers are to be expected or required prior to reimplan-
tation after long-lasting antibiotic treatment [8]. Ghanem et
al. retrospectively determined the value of erythrocyte
sedimentation rate and CRP serum levels before second-
stage reimplantation by receiver operating characteristic
curves (ROC). They attributed a poor performance to both
markers for the predilection of persistent infection. Cut-off
values could not be obtained because of high variance [8].
In contrast, Greidanus et al. prospectively assessed 151
knee arthroplasties and determined a CRP cut-off of
13.5 mg/l for PJI with a sensitivity and specificity of 91%
and 86%, respectively [20]. However, they only assessed
the accuracy for first-time PJI diagnosis and not the accuracy
for the detection of persistent infection after treatment,
which represents a different clinical situation. In a trial
with children with acute osteomyelitis, the peak CRP
value was reached on day 2. The decrease was very rapid,
Table 3 Comparison between the groups presenting arthroplasty infection recurrence vs. cure after a two-stage revision
All episodes(n=62) No recurrence(n=50) Recurrence(n=12) Odds ratio, 95%
confidence interval
p valuea
Patients
Female sex 25 (50%) 4 (33%) 0.5, 0.1–2.2 0.35
Median age 71 years 66 years 0.39
Chronic immunosuppressionb 27 (54%) 5 (42%) 0.6, 0.1–2.6 0.53
Median ASA-score 2 points 2 points 0.10
Hip arthroplasty compared to knee
arthroplasty
29 hips (62%) 7 hips (58%) 0.3, 0.1–2.6 1.0
Infection
Median delay between primary
arthroplasty and infection
883 days 623 days 0.63
Median delay between infection
and explantation
12.5 days 6.5 days 0.24
Presence of bacteremia 11 (22%) 1 (8%) 0.3, 0.1–2.7 0.43
Infection caused by Staphylococcus aureus 11 (22%) 4 (33%) 1.8, 0.3–8.2 0.46
Infection caused by coagulase-negative
staphylococci
17 (34%) 2 (17%) 0.4, 0.1–2.2 0.31
Infection caused by Streptococcus sp 12 (24%) 3 (25%) 1.1, 0.2–5.2 1.00
Infection caused by Gram-negative
pathogens
6 (12%) 1 (8%) 0.7, 0.1–6.5 1.00
Before reimplantation
Median duration of antibiotic treatment 43 days 51 days 0.71
Use of spacers 28 (56%) 9 (75%) 2.4, 0.5–15.0 0.33
Use of antibiotic-loaded spacers 14 (28%) 6 (50%) 2.6, 0.6–11.3 0.18
Median duration of antibiotic free window 56 days 25 days 0.53
Median last C-reactive protein value 6.0 mg/l 4.5 mg/l 0.59
Median last total leukocyte count 6.0 G/l 7.5 G/l 0.08
Median percentage of non-segmented
neutrophils
1% 1% 0.89
a Group comparisons were performed with the Wilcoxon rank sum test or the Fisher exact test, as appropriate
b Diabetes mellitus, transplant patient, chronic alcoholism, neoplasia, HIV infection, steroid treatment for autoimmune disease, dialysis
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with normal values reached within a week (mean 6.9 days)
[21]. Another paediatric study found a normalisation time
of serum CRP levels of only ten days during the treatment
of childhood bone and joint infections [22]. In adults, few
authors have investigated serum CRP levels with the
clinical response of surgical site infections after spinal
surgery. Although the CRP levels of patients at the four-
week-antibiotic treatment time point were lower than in
patients that healed well (mean CRP 0.3±0.5 mg/l) as
opposed to those with overt persistent infection (continuing
drainage, erythema; mean CRP 7.3±3.5 mg/L), CRP values
returned to normal within a few days [23]. In our study,
CRP values tended to decrease more rapidly during
antibiotic treatment in patients without recurrent infections
than in patients with recurrent PJI. However, these differ-
ences were not significant. To our best knowledge, there are
currently no prospective trials on serum inflammatory
markers in the predilection of persistent infection after
antibiotic treatment before second-stage reimplantation. As
for the accuracy of peripheral leukocyte counts, previous
reports failed to demonstrate a correlation with osteo-
articular infections [21, 24].
Our report has several limitations. First, it is a single-centre
retrospective study with a small number of cases, limiting the
general application of the results. Second, our patients had
quasi normal CRP and total leukocyte counts preceding
reimplantation. It could be that higher values would predict
PJI recurrence. However, in these cases, patients are also likely
to be symptomatic. Third, histology and PCR were not
sampled in all cases. Only in five PJIs was PCR used. Because
of this small number, we excluded PCR from analysis. In the
literature, PCRmay enhance sensitivity for first-time diagnosis
of PJI [25]. However, its value in the setting of pre-
reimplantational sampling after prolonged antibiotic treatment
is not yet established, unlike histology for which a high
accuracy has been attributed in this context [7]. Fourth,
although rare, infection by a new pathogen (instead of mere
recurrence) may also occur after a two-stage exchange of PJI.
It is debatable whether these new infections should be
counted as recurrences as we did in our study. This issue is
only sparsely reported in literature [6]. Fifth, no multivariate
analysis was performed to avoid overfitting and spurious
results. Thus, we cannot allow and adjust for potential
confounding factors.
As a conclusion, the benefit of pre-reimplantational
invasive cultures in the absence of clinical signs is probably
too small compared to its expense. Even when negative,
these cultures give no guarantee for absence of future
recurrence [3]. Further reports or trials are needed for these
invasive tests. For CRP as the hallmark and the best among
currently available clinical serum inflammatory markers
[26], a prospective trial during two-stage exchange is
warranted.
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